Kinnate Biopharma Inc. to Present Trial Design for its Pan-FGFR Inhibitor Product Candidate, KIN-3248, at ASCO 2022
Preclinical data from a study of the Company’s pan-RAF product candidate, KIN-2787, in combination with…
News
Harpoon Presents Interim Data from Ongoing Dose Escalation Portion of T Cell Engager HPN328 Clinical Trial at 2022 ASCO Annual Meeting
Clinically active and well tolerated in patients with solid tumors Favorable safety profile emerging: 22%…
IO Biotech Announces Two Presentations at the American Society of Clinical Oncology Annual Meeting 2022
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Adagene Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody® ADG126, with Repeat Dosing Across Dose Levels
– First clinical data demonstrating potential of SAFEbody technology platform to create…
Data from SOTIO’s Phase 1/1b AURELIO-03 Trial of SOT101 Demonstrate Clinical Benefit in Patients with Solid Tumors
Data demonstrate that SOT101 monotherapy and SOT101 in combination with pembrolizumab have a favorable safety…
Surface Oncology to Present New SRF388 Clinical Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
– SRF388 demonstrated clinical activity in multiple solid tumor types withthree confirmed partial responses across…
NKGen Biotech To Present SNK01 Clinical Data at the 2022 ASCO Annual Meeting
SANTA ANA, Calif., May 26, 2022 (GLOBE NEWSWIRE) — NKGen Biotech Inc., a biotechnology company…
Elevar Therapeutics Announces Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial
Results of open-label, multicenter study will be presented during a poster session at ASCO on…
Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Media Release Copenhagen, Denmark, May 26, 2022 Multiple epcoritamab (DuoBody®-CD3xCD20) poster presentations highlighting data in…
Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting
RECIST responses observed in IO-refractory patients and in IO-resistant indications 30% ORR in patients treated…
AB Science announces that Health Canada has started the review of New Drug Submission for masitinib in the treatment of ALS
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS STARTED THE REVIEW OF NEW DRUG…
Mercury Systems receives $7.9M order for high-performance processing systems
ANDOVER, Mass., May 26, 2022 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a…
Zscaler and Siemens Partnership Delivers All-in-One Solution to Accelerate Secure Digitalization for OT Environments
To be Demonstrated at Hannover Messe Fair, World’s First Zero Trust OT Security Platform Powered…
Cleantek Industries Inc. Announces Q1 2022 Results and Provides Operational Update
Calgary, Alberta–(Newsfile Corp. – May 26, 2022) – Cleantek Industries Inc. (TSXV: CTEK) (“Cleantek” or…
Tenet To Report Q1 2022 Financial Results on May 30
Toronto, Ontario–(Newsfile Corp. – May 26, 2022) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Let the World Hear the Voice of Jinan – The Jinan International Communication Center Has Been Officially Established
Jinan, Shandong, China–(Newsfile Corp. – May 26, 2022) – On May 24th 2022, the Jinan…
NACD North Texas Announces New Chapter Officers and Board Members for 2022–2023
DALLAS–(BUSINESS WIRE)–The NACD North Texas Chapter, the advocate for the profession of directorship, today announced…
NW Natural Water Continues Growth in Washington with Two More Acquisitions
PORTLAND, Ore.–(BUSINESS WIRE)–NW Natural Water Company, LLC (NW Natural Water), a wholly-owned subsidiary of Northwest…
Seven Hills Realty Trust Announces Annual Meeting Results
NEWTON, Mass.–(BUSINESS WIRE)–Seven Hills Realty Trust (Nasdaq: SEVN) announced the results of its 2022 Annual…
Valaris Announces New Executive Leadership Appointments
HAMILTON, Bermuda–(BUSINESS WIRE)–Valaris Limited (NYSE: VAL) (“Valaris” or the “Company”) today announced the appointment of…